Updated May 12, 2017 This content is archived.
An editorial by Andrew H. Talal, MD, professor of medicine, looks at the difficulties of screening, diagnosing and treating individuals infected with the hepatitis C virus who also have substance use disorders. “People with substance use disorders can account for as much as 80 percent of infected individuals in developed countries, a direct result of the opioid epidemic in the U.S.,” he said.